Filgrastim biosimilar (AqVida)

非格司亭生物类似药（AqVida）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (AqVida)

Drug Alias Name非格司亭生物仿制药（AqVida）rhG-CSF (AqVida)重组人粒细胞刺激因子（AqVida）Filgrastim follow-on biologic (AqVida)Recombinant human granulocyte macrophage colony stimulating facto (AqVida) +[6]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryRussian Federation

Original Approved Date2008/05/01

Country/TerritoryRussian FederationChileIraq

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesAqvida Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesAqvida Gmbh

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02